Dubbed the “Medicare Gold Rush,” Dr. Berwick and former CMS Deputy Administrator Richard Gilfillan, MD, cites current per-life valuations for Medicare Advantage beneficiaries at $87,000 on average — a steep increase over valuations between $4,000 and $10,500 in the past, according to the Sept. 29 piece.
What drives the gold rush is the anticipated growth of Medicare spending, historic CMS overpayments to Medicare Advantage plans, heavy marked subsidies and the Direct Contracting Model, which privatizes the landscape, according to the authors.
The authors also focus on “risk-score gaming,” which allows payers to drive overpayments by inaccurately pricing coming from CMS’s Hierarchical Condition Category. The practice, which is at the heart of the Medicare Advantage model, results in driving taxpayer dollars straight to payer pockets, the authors argue.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
